Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: Results from National Surgical Adjuvant Breast and Bowel Project C-04

Journal of Clinical Oncology

Volumn 17, Issue 11, 1999, Pages 3553-3559

  Wolmark, Norman ^a   Rockette, Howard ^a   Mamounas, Eleftherios ^a   Jones, Judy ^a   Wieand, Sam ^a   Wickerham, D L ^a   Bear, Harry D ^a   Atkins, James N ^a   Dimitrov, Nikolay V ^a   Glass, Andrew G ^a   Fisher, Edwin R ^a   Fisher, Bernard ^a  

^a NSABP Foundation Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LEVAMISOLE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLON CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0032729240     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1999.17.11.3553     Document Type: Article

References (16)

1. NIH Consensus Conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444-1450, 1990
2. Laurie JA, Moertel CG, Fleming TR, et al: Surgical adjuvant therapy of large bowel carcinoma: An evaluation of levamisole and the combination of levamisole and 5-fluorouracil. J Clin Oncol 7:1447-1456, 1989
3. Moertel CG, Fleming TR, McDonald TS, et al: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358, 1990
4. Moertel CG, Fleming TR, McDonald TS, et al: Fluorouracil plus levamisole after resection of stage III colon carcinoma: A final report. Ann Intern Med 122:321-326, 1995
5. Wolmark N, Rockette H, Fisher B, et al: The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project Protocol C-03. J Clin Oncol 11:1879-1887, 1993
6. Wolmark N, Rockette H, Mamounas EP, et al: The relative efficacy of 5FU + leucovorin, 5 FU + levamisole, and 5FU + leucovorin + levamisole in patients with Dukes B and C carcinoma of the colon: First report of NSABP C-04. Proc Am Soc Clin Oncol 15:205, 1996 (abstr 460)
7. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
8. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
9. Peto R, Peto J: Asymptotically efficient rank invariant test procedures. J R Stat Soc A 135:185-206, 1972
10. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
11. Fleming TR, Harrington DP, O'Brien PC: Designs for group sequential tests. Controlled Clin Trials 5:348-361, 1984
12. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators: Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345:939-944, 1995
13. O'Connell MJ, Mailliard JA, Kahn MJ, et al: Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 12:246-250, 1997
14. Haller DG, Catalano PJ, Macdonald JS, et al: Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: Five-year final report of INT-0089. Proc Am Soc Clin Oncol 17:256a, 1998 (abstr 982)
15. O'Connell MJ, Laurie JA, Kahn M, et al: Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 16:295-300 1998
16. Mamounas EP, Rockette H, Jones J, et al: Comparative efficacy of adjuvant chemotherapy in patients with Dukes B versus Dukes C colon cancer: Results from four NSABP adjuvant studies (C-01, C-02, C-03, C-04). Proc Am Soc Clin Oncol 15:205, 1996 (abstr 461)